$260 Million is the total value of Krensavage Asset Management, LLC's 10 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | United Therapeutics Corp | $43,072,000 | +0.3% | 540,094 | -1.9% | 16.54% | +18.6% |
| BIIB | Buy | Biogen Inc | $41,142,000 | -0.4% | 176,710 | +0.1% | 15.80% | +17.9% |
| MCK | Sell | McKesson Corp | $40,082,000 | -20.1% | 293,297 | -21.4% | 15.39% | -5.5% |
| GILD | Buy | Gilead Sciences Inc | $34,968,000 | -6.1% | 551,715 | +0.1% | 13.43% | +11.1% |
| ENTA | Buy | Enanta Pharmceuticals Inc | $29,972,000 | -25.9% | 498,874 | +4.0% | 11.51% | -12.4% |
| ALXN | New | Alexion Pharmaceuticals Inc | $24,975,000 | – | 255,000 | +100.0% | 9.59% | – |
| ELAN | Buy | Elanco Animal Health Inc | $23,735,000 | -21.3% | 892,620 | +0.1% | 9.11% | -6.9% |
| RTIX | Sell | RTI Surgical HDS Inc | $11,087,000 | -33.4% | 3,890,324 | -0.7% | 4.26% | -21.2% |
| IVC | Sell | Invacare Corp | $9,186,000 | +32.9% | 1,224,761 | -8.0% | 3.53% | +57.2% |
| AVNS | Buy | Avanos Medical Inc | $2,226,000 | -14.0% | 59,429 | +0.1% | 0.86% | +1.8% |
| AMGN | Exit | Amgen Inc | $0 | – | -215,402 | -100.0% | -12.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.